Antiglycation and Antioxidant Properties of Momordica charantia.

The accumulation of advanced glycation endproducts (AGEs) and oxidative stress underlie the pathogenesis of diabetic complications. In many developing countries, diabetes treatment is unaffordable, and plants such as bitter gourd (or bitter melon; Momordica charantia) are used as traditional remedie...

Full description

Bibliographic Details
Main Authors: Ali Aljohi, Sabine Matou-Nasri, Nessar Ahmed
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4981456?pdf=render
id doaj-49c9ed5c6e1b493d82590162bbd7d4d9
record_format Article
spelling doaj-49c9ed5c6e1b493d82590162bbd7d4d92020-11-25T00:07:59ZengPublic Library of Science (PLoS)PLoS ONE1932-62032016-01-01118e015998510.1371/journal.pone.0159985Antiglycation and Antioxidant Properties of Momordica charantia.Ali AljohiSabine Matou-NasriNessar AhmedThe accumulation of advanced glycation endproducts (AGEs) and oxidative stress underlie the pathogenesis of diabetic complications. In many developing countries, diabetes treatment is unaffordable, and plants such as bitter gourd (or bitter melon; Momordica charantia) are used as traditional remedies because they exhibit hypoglycaemic properties. This study compared the antiglycation and antioxidant properties of aqueous extracts of M. charantia pulp (MCP), flesh (MCF) and charantin in vitro. Lysozyme was mixed with methylglyoxal and 0-15 mg/ml of M. charantia extracts in a pH 7.4 buffer and incubated at 37°C for 3 days. Crosslinked AGEs were assessed using gel electrophoresis, and the carboxymethyllysine (CML) content was analyzed by enzyme-linked immunosorbent assays. The antioxidant activities of the extracts were evaluated using assays to assess DPPH (1,1-diphenyl-2-picryl-hydrazyl) and hydroxyl radical scavenging activities, metal-chelating activity and reducing power of the extracts. The phenolic, flavonol and flavonoid content of the extracts were also determined. All extracts inhibited the formation of crosslinked AGEs and CML in a dose-dependent manner, with MCF being the most potent. The antioxidant activity of MCF was higher than that of MCP, but MCP showed the highest metal-chelating activity. MCF had the highest phenolic and flavonoid contents, whereas MCP had the highest flavonol content. M. charantia has hypoglycaemic effects, but this study shows that M. charantia extracts are also capable of preventing AGE formation in vitro. This activity may be due to the antioxidant properties, particularly the total phenolic content of the extracts. Thus, the use of M. charantia deserves more attention, as it may not only reduce hyperglycaemia but also protect against the build-up of tissue AGEs and reduce oxidative stress in patients with diabetes.http://europepmc.org/articles/PMC4981456?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Ali Aljohi
Sabine Matou-Nasri
Nessar Ahmed
spellingShingle Ali Aljohi
Sabine Matou-Nasri
Nessar Ahmed
Antiglycation and Antioxidant Properties of Momordica charantia.
PLoS ONE
author_facet Ali Aljohi
Sabine Matou-Nasri
Nessar Ahmed
author_sort Ali Aljohi
title Antiglycation and Antioxidant Properties of Momordica charantia.
title_short Antiglycation and Antioxidant Properties of Momordica charantia.
title_full Antiglycation and Antioxidant Properties of Momordica charantia.
title_fullStr Antiglycation and Antioxidant Properties of Momordica charantia.
title_full_unstemmed Antiglycation and Antioxidant Properties of Momordica charantia.
title_sort antiglycation and antioxidant properties of momordica charantia.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2016-01-01
description The accumulation of advanced glycation endproducts (AGEs) and oxidative stress underlie the pathogenesis of diabetic complications. In many developing countries, diabetes treatment is unaffordable, and plants such as bitter gourd (or bitter melon; Momordica charantia) are used as traditional remedies because they exhibit hypoglycaemic properties. This study compared the antiglycation and antioxidant properties of aqueous extracts of M. charantia pulp (MCP), flesh (MCF) and charantin in vitro. Lysozyme was mixed with methylglyoxal and 0-15 mg/ml of M. charantia extracts in a pH 7.4 buffer and incubated at 37°C for 3 days. Crosslinked AGEs were assessed using gel electrophoresis, and the carboxymethyllysine (CML) content was analyzed by enzyme-linked immunosorbent assays. The antioxidant activities of the extracts were evaluated using assays to assess DPPH (1,1-diphenyl-2-picryl-hydrazyl) and hydroxyl radical scavenging activities, metal-chelating activity and reducing power of the extracts. The phenolic, flavonol and flavonoid content of the extracts were also determined. All extracts inhibited the formation of crosslinked AGEs and CML in a dose-dependent manner, with MCF being the most potent. The antioxidant activity of MCF was higher than that of MCP, but MCP showed the highest metal-chelating activity. MCF had the highest phenolic and flavonoid contents, whereas MCP had the highest flavonol content. M. charantia has hypoglycaemic effects, but this study shows that M. charantia extracts are also capable of preventing AGE formation in vitro. This activity may be due to the antioxidant properties, particularly the total phenolic content of the extracts. Thus, the use of M. charantia deserves more attention, as it may not only reduce hyperglycaemia but also protect against the build-up of tissue AGEs and reduce oxidative stress in patients with diabetes.
url http://europepmc.org/articles/PMC4981456?pdf=render
work_keys_str_mv AT alialjohi antiglycationandantioxidantpropertiesofmomordicacharantia
AT sabinematounasri antiglycationandantioxidantpropertiesofmomordicacharantia
AT nessarahmed antiglycationandantioxidantpropertiesofmomordicacharantia
_version_ 1725417317754470400